Enanta Pharmaceuticals Inc. ENTA
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Enanta Pharmaceuticals Inc. is a biotechnology company dedicated to the discovery and development of small molecule drugs. The primary focus of the company is on creating innovative treatments for viral infections and liver diseases. Enanta has a proven track record in drug discovery, having developed lead candidates f…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees120
TickerENTA
Statistics
Market Cap$362.5M
Revenue (TTM)$65.3M
Net Income-$81.9M
Net Margin-125.4%
EPS$-3.84
P/E-3.00
P/S4.84
P/B2.87
EV/EBITDA-6.45
ROE-59.0%
Dividend Yield—
Price$12.47
Data: Twelve Data · Revenue = mcap / P/S